Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-11-013845
Filing Date
2011-02-14
Accepted
2011-02-14 18:24:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g26130sc13gza.htm SC 13G/A 29224
  Complete submission text file 0000950123-11-013845.txt   30840
Mailing Address 1207 17TH AVENUE SUITE 103 NASHVILLE TN 37212
Business Address
KAZIMI A J (Filed by) CIK: 0001075050 (see all company filings)

Type: SC 13G/A

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 11608956
SIC: 2834 Pharmaceutical Preparations